Trials Both 1 False | Cancer Clinical Trials & Research Studies | NYU Langone Health | Page 4

Start Over

Trial Filters

Clear Trial Filters

Displaying 32 (all) recruiting clinical trials.

Not Accepting Healthy

First-in-Human Study of Mutant-Selective PI3Ka Inhibitor RLY- 2608 as a Single Agent in Advanced Solid Tumor Patients and in Combination with Fulvestrant in Patients with Advanced Breast Cancer

Phase Interventional
A Phase 1a/1b Trial of LY3962673 in Participants with KRAS G12D-Mutant Solid Tumors

This study is testing the tolerability, effectiveness, and potential for few side effects of the drug LY3962673 in patients with advanced solid tumors that have ...

Phase Interventional

«
←
1
2
3
4
→
»